{"id":689,"date":"2026-06-06T18:32:00","date_gmt":"2026-06-06T18:32:00","guid":{"rendered":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/"},"modified":"2026-06-07T22:59:34","modified_gmt":"2026-06-07T22:59:34","slug":"utm_campaignrss-4","status":"publish","type":"post","link":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/","title":{"rendered":"Lilly shares security, tolerability knowledge on its next-gen weight problems drug"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div data-author=\"elaine-chen\">\n<p class=\"author-bio\">Elaine\u2019s tales discover the increase in new weight problems therapies, new drug fee fashions, the methods corporations are affected by FDA adjustments, and the rising psychedelics drug sector. She co-writes The Readout e-newsletter, and co-hosts STAT\u2019s weekly biotech podcast, The Readout Loud. You possibly can attain Elaine on Sign at elaineywchen.70.<\/p>\n<\/div>\n<div>\n<p>Eli Lilly has already established that its next-generation weight problems drug can result in extremely fast weight reduction. Researchers disclosed new knowledge Saturday that present extra particulars on the security and tolerability of the closely-watched remedy.<\/p>\n<p>Lilly beforehand stated that in a single late-stage research, known as TRANSCEND-T2D-1, retatrutide helped individuals with diabetes decrease blood sugar and lose a big quantity of weight, which is notable since those that have diabetes are inclined to lose much less weight on therapy than those that don\u2019t.<\/p>\n<p>New knowledge confirmed that seven out of the 403 individuals who acquired retatrutide skilled arrhythmias (irregular coronary heart beats), and three handled individuals skilled main cardiovascular issues, in contrast with none within the placebo group. The information have been introduced on the annual assembly of the American Diabetes Affiliation and printed within the Lancet.<\/p>\n<div class=\"restricted-content-breaker article\" aria-labelledby=\"restricted-story-heading\" aria-describedby=\"restricted-story-description\" checked=\"false\">\n<div class=\"restricted-content-breaker-bar\">\n<p class=\"restricted-text\">STAT+ Unique Story<\/p>\n<p class=\"restricted-login\">Have already got an account? Log in<\/p>\n<\/p><\/div>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<div class=\"restricted-content-breaker-wrapper\">\n\t\t\t\t<span class=\"stat-paywall-archive\"><\/p>\n<p>\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t<\/span><\/p>\n<h2 id=\"restricted-story-heading\">This text is unique to STAT+ subscribers<\/h2>\n<h3 id=\"restricted-story-description\">Unlock this text \u2014 plus every day protection and evaluation of the pharma business \u2014 by subscribing to STAT+.<\/h3>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Have already got an account? Log in<\/p>\n<div class=\"restricted-content-breaker-cards\">\n<div class=\"slider-container\" aria-label=\"Subscription plan toggle\">\n\t\t\t\t\t\tParticular person plans<\/p>\n<p>\t\t\t\t\t\tGroup plans\n\t\t\t\t\t<\/p><\/div><\/div>\n<p>\t\t\t\tView All Plans\n\t\t\t<\/p><\/div><\/div>\n<div class=\"restricted-message-breaker\">\n<div class=\"restricted-content-wrapper\">\n<div class=\"restricted-content-message\">\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo learn the remainder of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\tSubscribe\n\t\t\t\t\t\t\t\t\t<\/p><\/div><\/div><\/div><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.statnews.com\/2026\/06\/06\/illy-retatrutide-triple-g-weight-loss-obesity-safety-data-ada\/?utm_campaign=rss\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Elaine\u2019s tales discover the increase in new weight problems therapies, new drug fee fashions, the methods corporations are affected by FDA adjustments, and the rising psychedelics drug sector. She co-writes The Readout e-newsletter, and co-hosts STAT\u2019s weekly biotech podcast, The Readout Loud. You possibly can attain Elaine on Sign at elaineywchen.70. Eli Lilly has already [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":691,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg","fifu_image_alt":"","jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_social_meta":[],"jnews_override_counter":[],"footnotes":""},"categories":[10],"tags":[160,497,979,225,981,318,590,980],"class_list":["post-689","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","tag-data","tag-drug","tag-lilly","tag-nextgen","tag-obesity","tag-safety","tag-shares","tag-tolerability"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lilly shares security, tolerability knowledge on its next-gen weight problems drug - Future News 24<\/title>\n<meta name=\"description\" content=\"Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association in New Orleans, on Saturday.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lilly shares security, tolerability knowledge on its next-gen weight problems drug - Future News 24\" \/>\n<meta property=\"og:description\" content=\"Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association in New Orleans, on Saturday.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/\" \/>\n<meta property=\"og:site_name\" content=\"Future News 24\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-06T18:32:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-07T22:59:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg\" \/>\n<meta name=\"author\" content=\"Future News 24\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Future News 24\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/\"},\"author\":{\"name\":\"Future News 24\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\"},\"headline\":\"Lilly shares security, tolerability knowledge on its next-gen weight problems drug\",\"datePublished\":\"2026-06-06T18:32:00+00:00\",\"dateModified\":\"2026-06-07T22:59:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/\"},\"wordCount\":267,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg\",\"keywords\":[\"data\",\"drug\",\"Lilly\",\"NextGen\",\"obesity\",\"safety\",\"Shares\",\"tolerability\"],\"articleSection\":[\"BioTechnology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/\",\"name\":\"Lilly shares security, tolerability knowledge on its next-gen weight problems drug - Future News 24\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg\",\"datePublished\":\"2026-06-06T18:32:00+00:00\",\"dateModified\":\"2026-06-07T22:59:34+00:00\",\"description\":\"Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association in New Orleans, on Saturday.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/06\\\/06\\\/utm_campaignrss-4\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/futurenews24.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lilly shares security, tolerability knowledge on its next-gen weight problems drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"name\":\"Future News 24\",\"description\":\"The Smart Hub for AI and Next-Gen Innovation\",\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/futurenews24.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\",\"name\":\"Future News 24\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"contentUrl\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"width\":250,\"height\":250,\"caption\":\"Future News 24\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\",\"name\":\"Future News 24\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"caption\":\"Future News 24\"},\"sameAs\":[\"https:\\\/\\\/futurenews24.com\"],\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/author\\\/mridulpahuja20\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lilly shares security, tolerability knowledge on its next-gen weight problems drug - Future News 24","description":"Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association in New Orleans, on Saturday.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/","og_locale":"en_US","og_type":"article","og_title":"Lilly shares security, tolerability knowledge on its next-gen weight problems drug - Future News 24","og_description":"Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association in New Orleans, on Saturday.","og_url":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/","og_site_name":"Future News 24","article_published_time":"2026-06-06T18:32:00+00:00","article_modified_time":"2026-06-07T22:59:34+00:00","og_image":[{"url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg","type":"","width":"","height":""}],"author":"Future News 24","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg","twitter_misc":{"Written by":"Future News 24","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/#article","isPartOf":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/"},"author":{"name":"Future News 24","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83"},"headline":"Lilly shares security, tolerability knowledge on its next-gen weight problems drug","datePublished":"2026-06-06T18:32:00+00:00","dateModified":"2026-06-07T22:59:34+00:00","mainEntityOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/"},"wordCount":267,"commentCount":0,"publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg","keywords":["data","drug","Lilly","NextGen","obesity","safety","Shares","tolerability"],"articleSection":["BioTechnology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/","url":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/","name":"Lilly shares security, tolerability knowledge on its next-gen weight problems drug - Future News 24","isPartOf":{"@id":"https:\/\/futurenews24.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/#primaryimage"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg","datePublished":"2026-06-06T18:32:00+00:00","dateModified":"2026-06-07T22:59:34+00:00","description":"Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association in New Orleans, on Saturday.","breadcrumb":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/#primaryimage","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/AdobeStock_517947710_Editorial_Use_Only-1024x576.jpeg"},{"@type":"BreadcrumbList","@id":"https:\/\/futurenews24.com\/index.php\/2026\/06\/06\/utm_campaignrss-4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/futurenews24.com\/"},{"@type":"ListItem","position":2,"name":"Lilly shares security, tolerability knowledge on its next-gen weight problems drug"}]},{"@type":"WebSite","@id":"https:\/\/futurenews24.com\/#website","url":"https:\/\/futurenews24.com\/","name":"Future News 24","description":"The Smart Hub for AI and Next-Gen Innovation","publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/futurenews24.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/futurenews24.com\/#organization","name":"Future News 24","url":"https:\/\/futurenews24.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/","url":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","contentUrl":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","width":250,"height":250,"caption":"Future News 24"},"image":{"@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83","name":"Future News 24","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","caption":"Future News 24"},"sameAs":["https:\/\/futurenews24.com"],"url":"https:\/\/futurenews24.com\/index.php\/author\/mridulpahuja20\/"}]}},"_links":{"self":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/comments?post=689"}],"version-history":[{"count":1,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/689\/revisions"}],"predecessor-version":[{"id":690,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/689\/revisions\/690"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media\/691"}],"wp:attachment":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media?parent=689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/categories?post=689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/tags?post=689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}